AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Nasal vaccine delivery platform data presented at vaccine conference.
2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Carrington Laboratories, Inc., (CARN) announced that results of an initial study sponsored by its subsidiary DelSite Biotechnologies, Inc., were presented at the 6th Annual Conference of Vaccine Research in Arlington, Virginia.
The study evaluated the effect of GelVac, a new nasal vaccine delivery platform, on antigen nasal residence time and immune response in a mouse model.
Two different types of antigens were used to evaluate immune response, a soluble protein antigen (diphtheria toxin mutant DT-CRM) and a viral subvirion antigen (inactivated subvirion split influenza virus).
Groups of mice were inoculated intranasally two or three times, 10 days apart, with GelVac formulations containing antigen compared to antigen alone, and mucosal antibody (IgA) and systemic antibody (IgG) titers were then ...
- GelVac(TM) Nasal Vaccine Delivery Platform Data Presented at 6th Annual...
- Press release article from: PR Newswire May 7, 2003 700+ words
...GelVac(TM), a new nasal vaccine delivery platform, on antigen nasal residence...said, "The GelVac Vaccine Delivery Platform has the potential advantage...simple and broad nasal vaccine delivery platform based on GelSite(TM...
- Carrington Subsidiary Receives NIAID Biodefense Award; DelSite Biotechnologies...
- Press release article from: PR Newswire March 4, 2004 700+ words
...DelSite's intranasal vaccine delivery platform technology. "Nasal vaccinations...powder system that improves vaccine delivery by reducing patient discomfort...a simple and broad nasal vaccine delivery platform based on GelSite(TM...
- GelVac nasal vaccine delivery platform data presented at 6th Annual Conference...
- News wire article from: Asia Africa Intelligence Wire May 7, 2003 700+ words
...evaluated the effect of GelVac, a new nasal vaccine delivery platform, on antigen nasal residence time and immune...responses. GelVac is a simple and broad nasal vaccine delivery platform based on GelSite polymer, a water-based in...
- AerovectRx Corp. Announces CDC Contract to Develop New Intranasal Flu Vaccine...
- Press release article from: Business Wire November 1, 2006 700+ words
...Prevention (CDC) to develop a new intranasal vaccine delivery platform for influenza. The objective of the contract...immunological and therapeutic applications of our delivery platform including biodefense readiness and treatment...
- AerovectRx Corp announces CDC contract to develop new intranasal flu vaccine...
- News wire article from: Chemical Business Newsbase November 1, 2006 700+ words
...750,000 contract from the US Centers for Disease Control and Prevention (CDC) to develop a new intranasal vaccine delivery platform for influenza. The objective of the contract is to develop a device and associated disposables to deliver vaccines...
- Cobra signs agreement with US Naval Medical Research Center to evaluate oral...
- Magazine article from: Pharmaceutical Processing November 1, 2006 700+ words
...Research Center of the US Navy to construct and test a vaccine against malaria using Cobra's proprietary ORT-VAC oral vaccine delivery technology. Malaria affects about 300-500 million people per year and is responsible for about 2.7 million deaths...
- AVAX Technologies Awarded Patent on New Vaccine Delivery Platform.
- Press release article from: PR Newswire November 6, 2000 700+ words
...production of inactive viral particles in the body, followed by immunization against the disease. The objective of this new delivery platform is to generate stronger immune responses in both human and veterinary applications, using inactive virus as the immune...
- Carrington Subsidiary Signs Master Research Agreement and Expands Facilities...
- Press release article from: PR Newswire July 21, 2004 700+ words
...virology and bacteriology for vaccine delivery. Carrington has had a long...GelVac(TM) intranasal powder vaccine delivery system," said Kenneth...is a simple and broad nasal vaccine delivery platform based on GelSite(TM) polymer...
- Carrington Subsidiary Reports Positive Progress on Powder Vaccine Delivery...
- Press release article from: PR Newswire May 27, 2004 700+ words
...GelVac(TM) intranasal powder vaccine delivery system demonstrated that GelVac...simple and broad nasal powder vaccine delivery platform based on GelSite(TM) polymer...GelVac(TM) intranasal powder vaccine delivery system. About DelSite DelSite...
- Carrington subsidiary reports positive progress on powder vaccine delivery...
- News wire article from: Asia Africa Intelligence Wire May 27, 2004 700+ words
...Biotechnologies subsidiary's GelVac intranasal powder vaccine delivery system demonstrated that GelVac formulations persist...polymer. GelVac is a simple and broad nasal powder vaccine delivery platform based on GelSite polymer, a proprietary, naturally...
Source: HighBeam Research, Nasal vaccine delivery platform data presented at vaccine conference.